Infection Assistants

Parasite-derived exosomes boost Leishmania infection in mice.

Written byRuth Williams
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Sand flyWIKIMEDIA, JAMES GATHANYProtozoan parasites of the Leishmania genus cause leishmaniasis—a spectrum of diseases that can be disfiguring, debilitating or even deadly. Residing in the guts of blood-sucking sand flies, the parasites are transmitted to humans and other mammals when the flies bite. Now, scientists have discovered that, along with the parasites, the flies expel parasite-derived vesicles called exosomes into their mammalian hosts. According to a paper published in Cell Reports today (October 22), these exosomes ramp up inflammation and boost parasite numbers during infection.

“[The work] adds to the collection of vector-associated factors that promote infection following transmission of Leishmania by sand fly bite,” said parasite biologist David Sacks of the National Institute of Allergy and Infectious Diseases (NIAID) in Bethesda, Maryland, who was not involved in the study. “It reinforces the point that sand flies are not just flying syringes, they don’t just deposit parasites and nothing else.”

Indeed, aside from regurgitating parasites into a mammal’s skin when it feeds, a sand fly spews salivary proteins, a parasite-secreted gel, and other factors, all of which influence the development of infection and outcome of disease, explained microbiologist and immunologist Nathan Peters of the University of Calgary who also did not participate in the study.

The release of exosomes—small vesicles ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • ruth williams

    Ruth is a freelance journalist. Before freelancing, Ruth was a news editor for the Journal of Cell Biology in New York and an assistant editor for Nature Reviews Neuroscience in London. Prior to that, she was a bona fide pipette-wielding, test tube–shaking, lab coat–shirking research scientist. She has a PhD in genetics from King’s College London, and was a postdoc in stem cell biology at Imperial College London. Today she lives and writes in Connecticut.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies